Key result
Administering fibrinolytics prior to transfer for STEMI resulted in similar median door-to-door times compared with transfer for primary PCI.
Why the study?
Does fibrinolysis prior to transfer improve door-to-door time and clinical outcomes compared to transfer for pPCI in STEMI patients with long transfer distances?
Cohort (n=259)
Yes
Does fibrinolysis prior to transfer improve door-to-door time and clinical outcomes compared to transfer for pPCI in STEMI patients with long transfer distances?
Administering fibrinolytics prior to transfer for STEMI patients with long transfer distances does not delay transfer and is associated with lower in-hospital mortality compared to direct transfer for pPCI.
Answers are grounded in this paper and cite their sources.
Similar door-to-door times with pre-transfer fibrinolysis; hypothesis-generating for outcomes in long-distance STEMI, needs RCTs.
BACKGROUND: Current guidelines recommend rapid initiation of reperfusion therapy for ST-elevation myocardial infarction (STEMI), with short-distance transfer for primary percutaneous coronary intervention (pPCI) preferred over fibrinolysis in non-pPCI-capable hospitals. Comparative outcomes in patients with longer transfer times are unclear. HYPOTHESIS: We designed this study to assess whether administering fibrinolytics prior to initiating longer-distance interhospital transfer in patients with STEMI leads to a delay in transfer or worse outcomes compared with transfer for pPCI. METHODS: We analyzed 259 STEMI patients transferred to a receiving pPCI-capable center in eastern North Carolina. The patients were divided into 2 groups, with 43 (16.6%) transferred for pPCI and the remaining 216 (83.4%) transferred following fibrinolysis. The primary endpoint was door-to-door time. We also compared stroke, death, significant bleeding, and combined outcomes between the 2 groups. RESULTS: The median door-to-door time was similar for pPCI and fibrinolysis patients (135 vs 128 minutes; P = 0.71). Median door-to-balloon time among pPCI patients was 182 minutes from the point of arrival at the referral hospital and 49 minutes from arrival at the receiving pPCI center. Median door-to-needle time in the fibrinolysis patients was 30 minutes, with rescue PCI eventually performed in 81 (37.5%) patients. In-hospital mortality was higher in patients with pPCI (9.3%) compared with fibrinolysis patients (1.9%; P = 0.03). Combined incidence of stroke, significant bleeding, and death was 14% in pPCI patients compared with 7% in fibrinolysis patients (P = 0.13). CONCLUSIONS: In settings with longer transfer distances, administering fibrinolytics prior to transfer to a pPCI-capable center did not cause any significant delay in transfer or worse outcomes.
No takes yet. Share an insight, caveat, or question.
Beri et al. (2010) conducted a cohort in ST-elevation myocardial infarction (n=259). Fibrinolysis prior to transfer vs. Transfer for primary percutaneous coronary intervention (pPCI) was evaluated on Door-to-door time (p=0.71). Administering fibrinolytics prior to transfer for STEMI resulted in similar median door-to-door times compared with transfer for primary PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: